Shares of Johnson & Johnson JNJ, -0.89% inched 0.71% higher to $173.68 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, +1.42% falling 1.15% to 3,921.05 and Dow Jones Industrial Average DJIA, +0.42% falling 0.71% to 31,761.54. This was the stock’s fourth consecutive day of gains. Johnson & Johnson closed $13.01 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. RHHVF, +1.27% fell 1.54% to $336.31, Merck & Co. Inc. MRK, -1.00% rose 0.84% to $91.29, and Pfizer Inc. PFE, -1.25% rose 1.02% to $52.30. Trading volume (4.4 M) remained 2.6 million below its 50-day average volume of 7.0 M.